PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 45 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 9,250 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 9,250 | -24.2% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 12,205 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 12,205 | +313.0% | 0.00% | – |
| Q4 2016 | $0 | – | 2,955 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 2,955 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 2,955 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $1,000 | 0.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | -50.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 2,955 | +34.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | +100.0% | 2,205 | +29.3% | 0.00% | 0.0% |
| Q4 2014 | $1,000 | – | 1,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $824,000 | 0.12% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $37,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 84,500 | $31,000 | 0.01% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $4,000 | 0.01% |
| WADE G W & INC | 80,000 | $30,000 | 0.01% |
| Estate Counselors, LLC | 10,000 | $4,000 | 0.00% |
| SABBY MANAGEMENT, LLC | 93,283 | $35,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,466 | $4,000 | 0.00% |
| ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $6,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 27,451 | $10,000 | 0.00% |